184 related articles for article (PubMed ID: 35451223)
1. Cyclodextrin-Derived ROS-Generating Nanomedicine with pH-Modulated Degradability to Enhance Tumor Ferroptosis Therapy and Chemotherapy.
Xu M; Zha H; Han R; Cheng Y; Chen J; Yue L; Wang R; Zheng Y
Small; 2022 May; 18(20):e2200330. PubMed ID: 35451223
[TBL] [Abstract][Full Text] [Related]
2. A nanoreactor boosts chemodynamic therapy and ferroptosis for synergistic cancer therapy using molecular amplifier dihydroartemisinin.
Yang XX; Xu X; Wang MF; Xu HZ; Peng XC; Han N; Yu TT; Li LG; Li QR; Chen X; Wen Y; Li TF
J Nanobiotechnology; 2022 May; 20(1):230. PubMed ID: 35568865
[TBL] [Abstract][Full Text] [Related]
3. A pH-sensitive imidazole grafted polymeric micelles nanoplatform based on ROS amplification for ferroptosis-enhanced chemodynamic therapy.
Zhang Z; Wang L; Guo Z; Sun Y; Yan J
Colloids Surf B Biointerfaces; 2024 May; 237():113871. PubMed ID: 38547796
[TBL] [Abstract][Full Text] [Related]
4. GSH/pH Dual Activatable Cross-linked and Fluorinated PEI for Cancer Gene Therapy Through Endogenous Iron De-Hijacking and in Situ ROS Amplification.
Yang S; Wu Y; Zhong W; Chen R; Wang M; Chen M
Adv Mater; 2024 Jan; 36(2):e2304098. PubMed ID: 37689975
[TBL] [Abstract][Full Text] [Related]
5. Boosting Reactive Oxygen Species Generation with a Dual-Catalytic Nanomedicine for Enhanced Tumor Nanocatalytic Therapy.
Su G; Xu H; Zhou F; Gong X; Tan S; He Y
ACS Appl Mater Interfaces; 2023 Dec; 15(51):59175-59188. PubMed ID: 38095444
[TBL] [Abstract][Full Text] [Related]
6. Lactic acid responsive sequential production of hydrogen peroxide and consumption of glutathione for enhanced ferroptosis tumor therapy.
Zou W; Gao F; Meng Z; Cai X; Chen W; Zheng Y; Ying T; Wang L; Wu J
J Colloid Interface Sci; 2024 Jun; 663():787-800. PubMed ID: 38442520
[TBL] [Abstract][Full Text] [Related]
7. Microenvironment-driven sequential ferroptosis, photodynamic therapy, and chemotherapy for targeted breast cancer therapy by a cancer-cell-membrane-coated nanoscale metal-organic framework.
Pan WL; Tan Y; Meng W; Huang NH; Zhao YB; Yu ZQ; Huang Z; Zhang WH; Sun B; Chen JX
Biomaterials; 2022 Apr; 283():121449. PubMed ID: 35247637
[TBL] [Abstract][Full Text] [Related]
8. ROS-responsive fluorinated polyethyleneimine vector to co-deliver shMTHFD2 and shGPX4 plasmids induces ferroptosis and apoptosis for cancer therapy.
Yang S; Wong KH; Hua P; He C; Yu H; Shao D; Shi Z; Chen M
Acta Biomater; 2022 Mar; 140():492-505. PubMed ID: 34879292
[TBL] [Abstract][Full Text] [Related]
9. Fenton reaction-independent ferroptosis therapy via glutathione and iron redox couple sequentially triggered lipid peroxide generator.
He YJ; Liu XY; Xing L; Wan X; Chang X; Jiang HL
Biomaterials; 2020 May; 241():119911. PubMed ID: 32143060
[TBL] [Abstract][Full Text] [Related]
10. GSH-responsive degradable nanodrug for glucose metabolism intervention and induction of ferroptosis to enhance magnetothermal anti-tumor therapy.
Liao Z; Wen E; Feng Y
J Nanobiotechnology; 2024 Apr; 22(1):147. PubMed ID: 38570829
[TBL] [Abstract][Full Text] [Related]
11. Oxidative stress-amplified nanomedicine for intensified ferroptosis-apoptosis combined tumor therapy.
Yu M; Yu J; Yi Y; Chen T; Yu L; Zeng W; Ouyang XK; Huang C; Sun S; Wang Y; Liu Y; Lin C; Wu M; Mei L
J Control Release; 2022 Jul; 347():104-114. PubMed ID: 35513212
[TBL] [Abstract][Full Text] [Related]
12. Nanocatalytic Theranostics with Glutathione Depletion and Enhanced Reactive Oxygen Species Generation for Efficient Cancer Therapy.
Fu LH; Wan Y; Qi C; He J; Li C; Yang C; Xu H; Lin J; Huang P
Adv Mater; 2021 Feb; 33(7):e2006892. PubMed ID: 33394515
[TBL] [Abstract][Full Text] [Related]
13. A ferroptosis-reinforced nanocatalyst enhances chemodynamic therapy through dual H
Zhu XY; Wang TY; Jia HR; Wu SY; Gao CZ; Li YH; Zhang X; Shan BH; Wu FG
J Control Release; 2024 Mar; 367():892-904. PubMed ID: 38278369
[TBL] [Abstract][Full Text] [Related]
14. Activatable nanomedicine for overcoming hypoxia-induced resistance to chemotherapy and inhibiting tumor growth by inducing collaborative apoptosis and ferroptosis in solid tumors.
Fu J; Li T; Yang Y; Jiang L; Wang W; Fu L; Zhu Y; Hao Y
Biomaterials; 2021 Jan; 268():120537. PubMed ID: 33260096
[TBL] [Abstract][Full Text] [Related]
15. Functionalized Fe-Doped Carbon Dots Exhibiting Dual Glutathione Consumption to Amplify Ferroptosis for Enhanced Cancer Therapy.
Zhou M; Yang Z; Yin T; Zhao Y; Wang CY; Zhu GY; Bai LP; Jiang ZH; Zhang W
ACS Appl Mater Interfaces; 2023 Nov; 15(46):53228-53241. PubMed ID: 37943281
[TBL] [Abstract][Full Text] [Related]
16. Manganese porphyrin-based metal-organic framework for synergistic sonodynamic therapy and ferroptosis in hypoxic tumors.
Xu Q; Zhan G; Zhang Z; Yong T; Yang X; Gan L
Theranostics; 2021; 11(4):1937-1952. PubMed ID: 33408790
[TBL] [Abstract][Full Text] [Related]
17. Multifunctional carbon quantum dots as a theranostic nanomedicine for fluorescence imaging-guided glutathione depletion to improve chemodynamic therapy.
Li J; Hu ZE; We YJ; Liu YH; Wang N; Yu XQ
J Colloid Interface Sci; 2022 Jan; 606(Pt 2):1219-1228. PubMed ID: 34492460
[TBL] [Abstract][Full Text] [Related]
18. A tumor microenvironment responsive nanoplatform with oxidative stress amplification for effective MRI-based visual tumor ferroptosis.
Luo S; Ma D; Wei R; Yao W; Pang X; Wang Y; Xu X; Wei X; Guo Y; Jiang X; Yuan Y; Yang R
Acta Biomater; 2022 Jan; 138():518-527. PubMed ID: 34775124
[TBL] [Abstract][Full Text] [Related]
19. Improved Immune Response for Colorectal Cancer Therapy Triggered by Multifunctional Nanocomposites with Self-Amplifying Antitumor Ferroptosis.
Lin X; Chen H; Deng T; Cai B; Xia Y; Xie L; Wang H; Huang C
ACS Appl Mater Interfaces; 2024 Mar; 16(11):13481-13495. PubMed ID: 38456402
[TBL] [Abstract][Full Text] [Related]
20. Superoxide Dismutase-Like Regulated Fe/Ppa@PDA/B for Synergistically Targeting Ferroptosis/Apoptosis to Enhance Anti-Tumor Efficacy.
Ding X; Wang Z; Yu Q; MichaĆ N; Roman S; Liu Y; Peng N
Adv Healthc Mater; 2023 Nov; 12(29):e2301824. PubMed ID: 37485811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]